Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Ambros Therapeutics is a clinical-stage biotechnology company.
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Belite Bio is a clinical stage biopharmaceutical drug development company.
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
Bambusa Therapeutics operates as biotechnology company.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Indapta Therapeutics is a privately held biotechnology company.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 16 different industry categories.
Among tracked funding rounds, Dyne Therapeutics received $402.5M in a Post Ipo Equity round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include EvodiaBio, Jade Biosciences, Ambros Therapeutics, Tenaya Therapeutics, Dyne Therapeutics. These companies were founded in 2020 or later.